Stay updated on ALS Safety & Tolerability of Triumeq Clinical Trial
Sign up to get notified when there's something new on the ALS Safety & Tolerability of Triumeq Clinical Trial page.

Latest updates to the ALS Safety & Tolerability of Triumeq Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check77 days agoChange DetectedThe webpage has been updated to reflect a new version of the study, now labeled as revision v2.15.0, and includes the addition of key collaborators such as Macquarie University and the University of Sydney. The study's focus on the safety and tolerability of CUR-101 in patients with Amyotrophic Lateral Sclerosis (ALS) has been emphasized, while previous detailed descriptions of the study's design and methodology have been removed.SummaryDifference42%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to ALS Safety & Tolerability of Triumeq Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALS Safety & Tolerability of Triumeq Clinical Trial page.